Home
CVAC
CVAC News

Latest CureVac N.V. (CVAC) News on February 22, 2025

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?

Insider Monkey

2 days ago

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now?

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

ACCESS Newswire

4 days ago

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential

Simply Wall St.

12 days ago

Discovering Giftify And 2 Other US Penny Stocks With Promising Potential

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth

Simply Wall St.

a month ago

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

Yahoo Finance

a month ago

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

Moderna stock seesaws as first US bird flu death puts vaccine development in focus

Yahoo Finance

a month ago

Moderna stock seesaws as first US bird flu death puts vaccine development in focus

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Zacks

a month ago

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

Barrons.com

a month ago

Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death

Discover 3 US Penny Stocks With Market Caps Over $200M

Simply Wall St.

2 months ago

Discover 3 US Penny Stocks With Market Caps Over $200M

Cerus And 2 Other US Penny Stocks To Watch

Simply Wall St.

3 months ago

Cerus And 2 Other US Penny Stocks To Watch

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

Simply Wall St.

3 months ago

Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Zacks

3 months ago

Is the Options Market Predicting a Spike in CureVac (CVAC) Stock?

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

Insider Monkey

3 months ago

Is CureVac N.V. (CVAC) the Best German Stock to Buy Now?

Where are they now? 4 biotechs that soared then crashed during the pandemic

Pharma Voice

3 months ago

Where are they now? 4 biotechs that soared then crashed during the pandemic

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

GuruFocus.com

3 months ago

CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ...

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

ACCESSWIRE

3 months ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

ACCESSWIRE

3 months ago

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

MT Newswires

4 months ago

CureVac Appoints Axel Sven Malkomes as CFO

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

ACCESSWIRE

4 months ago

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

CureVac to Present at the 12th International mRNA Health Conference

ACCESSWIRE

4 months ago

CureVac to Present at the 12th International mRNA Health Conference

US Penny Stocks To Watch In October 2024

Simply Wall St.

4 months ago

US Penny Stocks To Watch In October 2024

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

The Wall Street Journal

4 months ago

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

ACCESSWIRE

4 months ago

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Morningstar Research

4 months ago

Analyst Report: CureVac N.V.

MT Newswires

4 months ago

Pfizer, BioNTech Win Legal Dispute Against CureVac's UK COVID Patents

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

Reuters

4 months ago

Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents

CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms

Simply Wall St.

5 months ago

CureVac N.V.'s (NASDAQ:CVAC) top owners are individual investors with 35% stake, while 31% is held by private equity firms

MT Newswires

5 months ago

CureVac Says CVGBM Cancer Vaccine Induces 77% T-Cell Response in Early-Stage Trial in Glioblastoma

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

ACCESSWIRE

5 months ago

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

Zacks

5 months ago

GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program

ACCESSWIRE

5 months ago

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

ACCESSWIRE

5 months ago

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat

Simply Wall St.

6 months ago

News Flash: 8 Analysts Think CureVac N.V. (NASDAQ:CVAC) Earnings Are Under Threat

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

CureVac Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Morningstar Research

6 months ago

Analyst Report: CureVac N.V.

MT Newswires

6 months ago

CureVac Doses First Patient in Part B of Cancer Vaccine Candidate Study

MT Newswires

6 months ago

CureVac's Q2 Pre-Tax Loss Widens, Revenue Rises; Finance Chief Pierre Kemula to Depart

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

ACCESSWIRE

6 months ago

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

ACCESSWIRE

6 months ago

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

ACCESSWIRE

6 months ago

CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

6 months ago

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth

Simply Wall St.

7 months ago

We Think CureVac (NASDAQ:CVAC) Can Afford To Drive Business Growth

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

7 months ago

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

7 months ago

CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

ACCESSWIRE

7 months ago

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

Simply Wall St.

8 months ago

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

Morningstar Research

8 months ago

Analyst Report: CureVac N.V.

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Zacks

8 months ago

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

Zacks

8 months ago

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

CureVac announces restructuring to focus on mRNA projects

Pharmaceutical Technology

8 months ago

CureVac announces restructuring to focus on mRNA projects

MT Newswires

8 months ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

Investopedia

8 months ago

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

MT Newswires

8 months ago

Sector Update: Health Care

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Barrons.com

8 months ago

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

Zacks

8 months ago

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

MT Newswires

8 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires

8 months ago

Sector Update: Health Care

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

MT Newswires

8 months ago

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

CureVac cuts jobs, licenses out vaccines to GSK

BioPharma Dive

8 months ago

CureVac cuts jobs, licenses out vaccines to GSK

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

The Wall Street Journal

8 months ago

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

GSK and CureVac restructure mRNA vaccine development deal

Pharmaceutical Technology

8 months ago

GSK and CureVac restructure mRNA vaccine development deal

MT Newswires

8 months ago

CureVac Enters Into New Licensing Agreement With GSK; to Implement 'Significant' Restructuring; Shares Rise Pre-Bell

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

ACCESSWIRE

8 months ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

ACCESSWIRE

8 months ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

GSK buys COVID, influenza vaccines from retrenching CureVac

Reuters

8 months ago

GSK buys COVID, influenza vaccines from retrenching CureVac

CureVac Announces Voting Results of General Meeting

ACCESSWIRE

8 months ago

CureVac Announces Voting Results of General Meeting

Morningstar Research

8 months ago

Analyst Report: CureVac N.V.

Morningstar Research

9 months ago

Analyst Report: CureVac N.V.

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

ACCESSWIRE

9 months ago

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

CureVac N.V. (NASDAQ:CVAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

9 months ago

CureVac N.V. (NASDAQ:CVAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

CureVac First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

9 months ago

CureVac First Quarter 2024 Earnings: Misses Expectations

Morningstar Research

9 months ago

Analyst Report: CureVac N.V.

Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks

The Wall Street Journal

9 months ago

Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

Zacks

9 months ago

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

ACCESSWIRE

9 months ago

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates

Simply Wall St.

10 months ago

Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates

CureVac Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

10 months ago

CureVac Full Year 2023 Earnings: Misses Expectations

CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript

Insider Monkey

10 months ago

CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript

Morningstar Research

10 months ago

Analyst Report: CureVac N.V.

MT Newswires

10 months ago

CureVac Begins Early Stage Portion of Investigational Vaccine Trial

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

ACCESSWIRE

10 months ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

ACCESSWIRE

10 months ago

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

ACCESSWIRE

10 months ago

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

CureVac to cut costs in restructuring

BioPharma Dive

10 months ago

CureVac to cut costs in restructuring

CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%

Simply Wall St.

10 months ago

CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%

CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024

ACCESSWIRE

10 months ago

CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024

CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines

ACCESSWIRE

10 months ago

CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines

CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

ACCESSWIRE

a year ago

CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

Morningstar Research

a year ago

Analyst Report: CureVac N.V.

Redfin to Announce Fourth-Quarter 2023 Results on February 27, 2024

Business Wire

a year ago

Redfin to Announce Fourth-Quarter 2023 Results on February 27, 2024

Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation

Simply Wall St.

a year ago

Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation

Aspen Aerogels to Present at Wolfe Research's Global Auto and Auto Tech Conference

PR Newswire

a year ago

Aspen Aerogels to Present at Wolfe Research's Global Auto and Auto Tech Conference

Look Beyond Profit, Bet on 4 Stocks With Increasing Cash Flows

Zacks

a year ago

Look Beyond Profit, Bet on 4 Stocks With Increasing Cash Flows

15 Best Places in Louisiana for a Couple to Live on Only Social Security

Insider Monkey

a year ago

15 Best Places in Louisiana for a Couple to Live on Only Social Security

Brookline Bancorp, Inc. (NASDAQ:BRKL) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Brookline Bancorp, Inc. (NASDAQ:BRKL) Q4 2023 Earnings Call Transcript

18 Best 52-Week Low Stocks To Buy Now

Insider Monkey

a year ago

18 Best 52-Week Low Stocks To Buy Now

Armour Residential REIT (ARR) Flat As Market Sinks: What You Should Know

Zacks

a year ago

Armour Residential REIT (ARR) Flat As Market Sinks: What You Should Know

20 States Where You May Not Be Able to Retire at Age 65

Insider Monkey

a year ago

20 States Where You May Not Be Able to Retire at Age 65

Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

Zacks

a year ago

Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

Share on Social Networks: